Screener
Thermo Fisher Scientific TMO Asia-Pacific — Consolidated revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 11:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000097745-26-000092
FAQ
- What is Thermo Fisher Scientific's asia-pacific — consolidated revenues?
- Thermo Fisher Scientific (TMO) reported asia-pacific — consolidated revenues of $1.97B in Q1 2026.
- How has Thermo Fisher Scientific's asia-pacific — consolidated revenues changed year-over-year?
- Thermo Fisher Scientific's asia-pacific — consolidated revenues increased by 4.2% year-over-year, from $1.89B to $1.97B.
- What is the long-term trend for Thermo Fisher Scientific's asia-pacific — consolidated revenues?
- Over 4 years (2021 to 2025), Thermo Fisher Scientific's asia-pacific — consolidated revenues has grown at a 2.9% compound annual growth rate (CAGR), from $7.22B to $8.1B.
- What does asia-pacific — consolidated revenues mean?
- This metric represents the total gross revenue generated by the company's operations within the Asia-Pacific geographic region. It encompasses sales from all business segments, including scientific instruments, laboratory equipment, diagnostics, and life science services, reflecting the company's market penetration and demand in this specific territory. Monitoring this figure helps assess the company's growth trajectory and competitive standing in key emerging and developed Asian markets.
Ask your AI about Thermo Fisher Scientific's asia-pacific — consolidated revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude